Human milk oligosaccharides (HMOs) are complex mixed oligosaccharides that naturally exist in human milk. They are the third largest component in human milk, second only to lactose and fat, accounting for approximately 8% of the total composition. These oligosaccharides have biological activities such as regulating immunity, anti-inflammatory, and anti-infection, and play an important role in infant intestinal health and immune system development. Therefore, human milk oligosaccharides have been widely used in infant formula.
Overview and Segmentation Analysis of the Global Human Milk Oligosaccharide Market
Driven by consumer preferences for bioactive additives and essential nutrients, the global market for human milk oligosaccharides is showing a rapid growth trend. According to our research data, the global market size of human milk oligosaccharides is expected to reach $173 million in 2023. In the coming years, with the continuous updates and progress of technology and systems, the quality of human milk oligosaccharide products will be correspondingly improved, bringing more development opportunities to the market. It is expected that the global market size of human milk oligosaccharides will increase to $376 million by 2028.
Human milk oligosaccharides include neutral oligosaccharides and acidic oligosaccharides. Neutral oligosaccharides, accounting for about 70% of the mass fraction of oligosaccharides in human milk, can also be divided into oligosaccharides without fucose groups and oligosaccharides containing fucose groups; Acidic oligosaccharides are oligosaccharides containing sialic acid and sulfate structures, accounting for approximately 30% of the mass fraction of human milk oligosaccharides. Data shows that in 2023, the global market size for neutral human milk oligosaccharides is estimated to reach $128 million, with a market share of 73.99%.
From the perspective of downstream application patterns, the field of infant formula milk powder is the largest downstream application market for human milk oligosaccharides. Data shows that the market size of human milk oligosaccharides used in infant formula is expected to reach $124 million in 2023, with an estimated market share of 71.68%. In addition, human milk oligosaccharides are also used in food supplements, functional foods, and beverages.
Global Human Milk Oligosaccharide Market Size Forecast and Market Segmentation Analysis
Source: www.globalmarketmonitor.com
Analysis of the Development of Human Milk Oligosaccharide Markets in Major Regions and Countries
Research shows that Europe is the industry's largest revenue market. Based on our research data, the estimated market size of human milk oligosaccharides in Europe in 2023 is $74 million, with an expected proportion of 42.77% in the global market; The North American market is expected to rank second with a share of 32.37%, with an estimated market size of $56 million for human milk oligosaccharides in 2023; The Chinese market may become the third largest revenue market for the global human milk oligosaccharide industry with a market revenue of $21 million and a share of 12.14%.
Global Human Milk Oligosaccharide Market Revenue and Share Forecast by Region/Country in 2023
|
Regions/Countries
|
Market Revenue (Million USD)
|
Market Share
|
|
North America
|
56
|
32.37%
|
|
Europe
|
74
|
42.77%
|
|
China
|
21
|
12.14%
|
|
Japan
|
7
|
4.05%
|
|
India
|
5
|
2.89%
|
|
South America
|
2
|
1.16%
|
|
Middle East & Africa
|
2
|
1.16%
|
Source: www.globalmarketmonitor.com
For more information, please click:《China Human Milk Oligosaccharide Industry Market Research Report 2023-2029》.
Chinese